Zeng et al. demonstrated that resveratrol can alleviate sepsis-induced cardiomyopathy by activating SIRT1 and upregulating the expression of NRF2 to against ferroptosis (Zeng et al., 2023). This evidence concerns the gene NFE2L2 and cardiomyopathy.